右美托咪定对头颈游离皮瓣术后结局的影响
DEX组术后谵妄发生率显著降低,镇静使用时间和ICU停留时间缩短,多因素分析显示DEX使用与躁动减少(OR 2.25,95%CI 1.17-4.36,P=0.016)及机械通气时间缩短显著相关,肺部感染和皮瓣并发症无显著差异。
要点
- DEX组术后谵妄发生率显著低于传统镇静剂组。
- DEX使用与躁动减少独立相关(OR 2.25,95%CI 1.17-4.36,P=0.016)。
- DEX组镇静使用时间和ICU停留时间缩短,皮瓣并发症无增加。
核心结论
- 头颈癌切除并即刻游离皮瓣重建术后使用DEX可能通过减少谵妄、躁动和ICU停留时间改善ICU术后管理质量,且不增加手术并发症。
主要发现
- DEX组术后谵妄发生率显著降低。
- DEX组镇静使用时间和ICU停留时间均缩短。
- 多因素分析显示DEX使用与躁动减少显著相关(OR 2.25,95%CI 1.17-4.36,P=0.016),并与机械通气时间缩短相关。
- 两组肺部感染和游离皮瓣并发症无显著差异。
临床怎么用
- 对头颈癌游离皮瓣重建术后ICU患者,可考虑使用DEX替代传统镇静剂以降低谵妄和躁动风险、缩短ICU停留时间。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
INTRODUCTION: Midazolam is commonly used as a traditional sedative for the postoperative care of patients with head and neck cancer undergoing free flap reconstruction. To improve the quality of postoperative management, this study aimed to investigate whether the use of dexmedetomidine (DEX) in such patients reduces the risks of agitation, delirium, and postoperative complications compared with traditional sedatives. MATERIALS AND METHODS: Patients who underwent wide excision of head and neck cancer followed by immediate microvascular free flap reconstruction between July 2021 and December 2023 were enrolled. All patients received either midazolam or DEX for sedation in the intensive care unit (ICU). Data collected included patient demographics, cancer-related history, perioperative characteristics, and postoperative outcomes, such as duration of mechanical ventilation, incidence of agitation and delirium, pulmonary infections, ICU length of stay, and complications related to free flap reconstruction. RESULTS: A total of 265 patients were included and divided into a traditional sedative group (n = 204) and a DEX group (n = 61). The DEX group demonstrated a significantly lower incidence of postoperative delirium. In addition, both the duration of sedative use and the length of ICU stay were reduced in the DEX group. Multivariate analysis revealed that DEX use was significantly associated with reduced agitation (odds ratio, 2.25; 95% confidence interval, 1.17-4.36; P = 0.016) and shorter mechanical ventilation time. No significant differences were observed between the 2 groups in terms of pulmonary infections or free flap complications. CONCLUSIONS: The use of DEX following head and neck cancer resection with immediate microvascular free flap reconstruction may enhance the quality of postoperative care in the ICU by reducing delirium, agitation, and length of ICU stay without increasing surgical complications.
引用
- Lin YY, Lin YT, Hung KS, et al. Impact of Dexmedetomidine on Postoperative Outcomes in Head and Neck Free Flap Surgery. Ann Plast Surg. 2025. PMID: 41358989. doi:10.1097/SAP.0000000000004553
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。